Quantum量子訊息有限公司
← 最新全球產業報告

Injectable Drug Delivery Market

研究執行與發布:Coherent Market Insights · 發布日期 2026-01-30 · 151 頁
由量子訊息有限公司(Quantum Information)在台灣代理銷售與提供授權諮詢。

2026 年市場規模
USD 650 Bn
2033 年預估規模
USD 900 Bn
年複合成長率 CAGR
7%

以上數字由 Coherent Market Insights 於本報告中提出,量子訊息原樣引用。

出版商 Coherent Market Insights產業別 Medical Devices出版日期 2026-01-30頁數 151報告編號 CMI2768

授權報價

Single User Price$4,500 USD
Enterprise License$10,000 USD
洽詢購買 申請 Sample
完整報告名稱與涵蓋範圍
Injectable Drug Delivery Market, By Device Type (Prefilled Syringes, Auto Injectors, Pens, Conventional Syringes, Cartridges, Ampoules, Vials, and Others), By Material Type (Glass and Plastic), By Usability (Disposable and Reusable), By Route of Administration (Intravenous, Intramuscular, and Subcutaneous), By End User (Hospitals, Clinics, Ambulatory Surgical Centers, Home Care Settings, and Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

報告摘要

Injectables offer maximum bioavailability of drugs towards the intended site of action and avoid the first pass metabolism. The injectable route is mostly preferred for the drugs which can’t be taken orally or have some stability problems. Unconscious patients or patients having low compliance towards oral tablets or capsules can be preferred for the injectable drug delivery therapy. Market Dynamics Increasing prevalence of chronic diseases such as diabetes, cardiac diseases, and anaphylaxis has supported growth of global injectable drug delivery market. According to the Allergy, Asthma & Clinical Immunology, in 2015, around 15 million people suffered from food allergies in the U.K. Similarly, according to the European Academy of Allergy and Clinical Immunology (EAACI), in 2015, around 17 million people suffered from food allergies in the U.K., of which around 3.5 million were children. Increasing awareness regarding safety and concern of needlestick injuries is a major factor driving growth of the injectable drug delivery market. For instance, the WHO recommended the use of safety syringes with sharp injury protection (SIP), in order to prevent needlestick injuries. Similarly, in May 2017, Innovative Neurons LLC announced to commercialize its patented auto retractable multi-needle syringe known as FAST (fast, accessible, safe, and technology) to decrease needlestick injuries. Various market players are focusing on the development and advancement in this space. For instance, ACT-O-VIAL System offered by Pfizer Inc. is a dual-component vial system that allows reconstitution of sterile, injectable medications by pressing on the plastic cap. The facility launch by market players to cater requirements of patients is expected to drive the market growth. For instance, in July 2018, Pfizer, Inc. announced to build sterile injectable pharmaceutical production facilities in the Michigan, U.S. However, product recalls by the manufacturers is the major factors restraining the market over the forecast period. For instance, in April 2018, Becton Dickson and Company announced a recall of PosiFlush Heaparin Lock Flush Syringe, and Prefilled normal saline syringe, owing to the contamination with Serratia marcescens bacterium. Key features of the study • This report provides in-depth analysis of the injectables drug delivery market and provides market size (USD million) and compound annual growth rate (CAGR %) for the forecast period (2018 – 2026), considering 2017 as the base year • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategy adopted by key players • It profiles key players in the global injectable drug delivery market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans • Key companies covered as a part of this study include, Becton, Dickinson and Company, Pfizer Inc., Novo Nordisk A/S, Gerresheimer AG, Carl-Zeiss-Stiftung, Terumo Corporation, Vetter Pharma-Fertigung GmbH & Co. KG, SHL Group, Owen Mumford Limited, Injex Pharma GmbH. • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics. • The global injectables drug delivery market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global injectable drug delivery market Market Segmentation • Device Type Insights (Revenue, USD Bn, 2026 - 2033) o Prefilled Syringes o Auto Injectors o Pens o Conventional Syringes o Cartridges o Ampoules o Vials o Others • Material Type Insights (Revenue, USD Bn, 2026 - 2033) o Glass o Plastic • Usability Insights (Revenue, USD Bn, 2026 - 2033) o Disposable o Reusable • Route of Administration Insights (Revenue, USD Bn, 2026 - 2033) o Intravenous o Intramuscular o Subcutaneous • End User Insights (Revenue, USD Bn, 2026 - 2033) o Hospitals o Clinics o Ambulatory Surgical Centers o Home Care Settings o Others • Regional Insights (Revenue, USD Bn, 2026 - 2033) o North America  U.S.  Canada o Latin America  Brazil  Argentina  Mexico  Rest of Latin America o Europe  Germany  U.K.  France  Italy  Russia  Rest of Europe o Asia Pacific  China  India  Japan  Australia  South Korea  ASEAN  Rest of Asia Pacific o Middle East  GCC  Israel  Rest of Middle East o Africa  North Africa  Central Africa  South Africa • Key Players Insights o Becton, Dickinson and Company o Pfizer Inc. o Novo Nordisk A/S o Gerresheimer AG o Carl-Zeiss-Stiftung o Terumo Corporation o Vetter Pharma-Fertigung GmbH & Co. KG o SHL Group o Owen Mumford Limited o Injex Pharma GmbH
目錄 Table of Contents
Table of Contents 1. Research Objectives and Assumptions o Research Objectives o Assumptions o Abbreviations 2. Market Overview o Report Description  Market Definition and Scope o Executive Summary  Global Injectable Drug Delivery Market, By Device Type  Global Injectable Drug Delivery Market, By Material Type  Global Injectable Drug Delivery Market, By Usability  Global Injectable Drug Delivery Market, By Route of Administration  Global Injectable Drug Delivery Market, By End User  Global Injectable Drug Delivery Market, By Region 3. Market Dynamics, Regulations, and Trends Analysis o Market Dynamics o Impact Analysis o Key Highlights o Regulatory Scenario o Product Launches/Approvals o PEST Analysis o PORTER’s Analysis o Market Opportunities o Regulatory Scenario o Key Developments o Industry Trend 4. Global Injectable Drug Delivery Market, By Device Type, 2020-2033, (USD Bn) o Introduction  Market Share Analysis, 2026 and 2033 (%)  Y-o-Y Growth Analysis, 2021 - 2033  Segment Trends o Prefilled Syringes  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Bn) o Auto Injectors  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Bn) o Pens  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Bn) o Conventional Syringes  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Bn) o Cartridges  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Bn) o Ampoules  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Bn) o Vials  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Bn) o Others  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Bn) 5. Global Injectable Drug Delivery Market, By Material Type, 2020-2033, (USD Bn) o Introduction  Market Share Analysis, 2026 and 2033 (%)  Y-o-Y Growth Analysis, 2021 - 2033  Segment Trends o Glass  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Bn) o Plastic  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Bn) 6. Global Injectable Drug Delivery Market, By Usability, 2020-2033, (USD Bn) o Introduction  Market Share Analysis, 2026 and 2033 (%)  Y-o-Y Growth Analysis, 2021 - 2033  Segment Trends o Disposable  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Bn) o Reusable  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Bn) 7. Global Injectable Drug Delivery Market, By Route of Administration, 2020-2033, (USD Bn) o Introduction  Market Share Analysis, 2026 and 2033 (%)  Y-o-Y Growth Analysis, 2021 - 2033  Segment Trends o Intravenous  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Bn) o Intramuscular  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Bn) o Subcutaneous  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Bn) 8. Global Injectable Drug Delivery Market, By End User, 2020-2033, (USD Bn) o Introduction  Market Share Analysis, 2026 and 2033 (%)  Y-o-Y Growth Analysis, 2021 - 2033  Segment Trends o Hospitals  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Bn) o Clinics  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Bn) o Ambulatory Surgical Centers  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Bn) o Home Care Settings  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Bn) o Others  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Bn) 9. Global Injectable Drug Delivery Market, By Region, 2020 - 2033, Value (USD Bn) o Introduction  Market Share (%) Analysis, 2026, 2028 & 2033, Value (USD Bn)  Market Y-o-Y Growth Analysis (%), 2021 - 2033, Value (USD Bn)  Regional Trends o North America  Introduction  Market Size and Forecast, By Device Type, 2020 - 2033, Value (USD Bn)  Market Size and Forecast, By Material Type, 2020 - 2033, Value (USD Bn)  Market Size and Forecast, By Usability, 2020 - 2033, Value (USD Bn)  Market Size and Forecast, By Route of Administration, 2020 - 2033, Value (USD Bn)  Market Size and Forecast, By End User, 2020 - 2033, Value (USD Bn)  Market Size and Forecast, By Country, 2020 - 2033, Value (USD Bn) o U.S. o Canada o Latin America  Introduction  Market Size and Forecast, By Device Type, 2020 - 2033, Value (USD Bn)  Market Size and Forecast, By Material Type, 2020 - 2033, Value (USD Bn)  Market Size and Forecast, By Usability, 2020 - 2033, Value (USD Bn)  Market Size and Forecast, By Route of Administration, 2020 - 2033, Value (USD Bn)  Market Size and Forecast, By End User, 2020 - 2033, Value (USD Bn)  Market Size and Forecast, By Country, 2020 - 2033, Value (USD Bn) o Brazil o Argentina o Mexico o Rest of Latin America o Europe  Introduction  Market Size and Forecast, By Device Type, 2020 - 2033, Value (USD Bn)  Market Size and Forecast, By Material Type, 2020 - 2033, Value (USD Bn)  Market Size and Forecast, By Usability, 2020 - 2033, Value (USD Bn)  Market Size and Forecast, By Route of Administration, 2020 - 2033, Value (USD Bn)  Market Size and Forecast, By End User, 2020 - 2033, Value (USD Bn)  Market Size and Forecast, By Country, 2020 - 2033, Value (USD Bn) o Germany o U.K. o Spain o France o Italy o Russia o Rest of Europe o Asia Pacific  Introduction  Market Size and Forecast, By Device Type, 2020 - 2033, Value (USD Bn)  Market Size and Forecast, By Material Type, 2020 - 2033, Value (USD Bn)  Market Size and Forecast, By Usability, 2020 - 2033, Value (USD Bn)  Market Size and Forecast, By Route of Administration, 2020 - 2033, Value (USD Bn)  Market Size and Forecast, By End User, 2020 - 2033, Value (USD Bn)  Market Size and Forecast, By Country, 2020 - 2033, Value (USD Bn) o China o India o Japan o Australia o South Korea o ASEAN o Rest of Asia Pacific o Middle East  Introduction  Market Size and Forecast, By Device Type, 2020 - 2033, Value (USD Bn)  Market Size and Forecast, By Material Type, 2020 - 2033, Value (USD Bn)  Market Size and Forecast, By Usability, 2020 - 2033, Value (USD Bn)  Market Size and Forecast, By Route of Administration, 2020 - 2033, Value (USD Bn)  Market Size and Forecast, By End User, 2020 - 2033, Value (USD Bn)  Market Size and Forecast, By Country, 2020 - 2033, Value (USD Bn) o GCC Countries o Israel o Rest of Middle East o Africa  Introduction  Market Size and Forecast, By Device Type, 2020 - 2033, Value (USD Bn)  Market Size and Forecast, By Material Type, 2020 - 2033, Value (USD Bn)  Market Size and Forecast, By Usability, 2020 - 2033, Value (USD Bn)  Market Size and Forecast, By Route of Administration, 2020 - 2033, Value (USD Bn)  Market Size and Forecast, By End User, 2020 - 2033, Value (USD Bn)  Market Size and Forecast, By Country, 2020 - 2033, Value (USD Bn) o South Africa o North Africa o Central Africa 10. Competitive Landscape o Becton, Dickinson and Company  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Pfizer Inc.  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Novo Nordisk A/S  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Gerresheimer AG  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Carl-Zeiss-Stiftung  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Terumo Corporation  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Vetter Pharma-Fertigung GmbH & Co. KG  SHL Group  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Owen Mumford Limited  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Injex Pharma GmbH  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies 11. Analyst Recommendations o Wheel of Fortune o Analyst View o Coherent Opportunity Map 12. References and Research Methodology o References o Research Methodology o About us

提及公司

Becton, Dickinson and CompanyPfizer Inc.Novo Nordisk A/SGerresheimer AGCarl-Zeiss-StiftungTerumo CorporationVetter Pharma-Fertigung GmbH & Co. KGSHL GroupOwen Mumford LimitedInjex Pharma GmbH

同分類最新報告(醫療器材)

常見問題

這份報告可以先索取樣本嗎?

可以。建議購買前先申請樣本,提出申請後約 2 個工作天內提供,您可以先確認內容涵蓋範圍是否符合需求。

報告價格如何計算?

報告以美元標價,台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本(單人/多人/企業全站)價格不同,量子訊息會評估您的使用情境後提供最優惠報價。

下單後多久交付?如何付款?

一般 3–7 個工作天交付,實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票,30 天內電匯付款即可。

量子訊息有限公司為 Coherent Market Insights 在台灣的授權代理,提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們